Target intelligence / Profile preview

Transmembrane protein 276 (TMEM276)

Target
TMEM276
Molecular classification
Other (integral membrane protein)
01

Overview

Transmembrane protein 276 (TMEM276) is a poorly characterized integral membrane protein encoded by the human TMEM276 gene. Current genomic and protein prediction databases suggest TMEM276 is a membrane-associated protein that may bind zinc ions and is located in the membrane, nuclear envelope, and the perinuclear region of the cytoplasm[3]. There is no strong experimental evidence for its precise molecular or cellular function, it is not assigned to a major functional protein family (such as ion channel, transporter, receptor, or enzyme), and no data links it to specific diseases or therapeutic mechanisms. TMEM276 is part of the large TMEM (transmembrane protein) family, members of which are generally involved in a wide range of physiological processes including membrane organization and signaling; however, the specific role of TMEM276 remains to be elucidated[3][4]. No approved drugs, clinical biomarkers, or experimental mechanisms of pharmacologic action are known for TMEM276 at this time, and it is not categorized as a therapeutic target in the current literature[3][4].

Other names
Transmembrane protein 276TMEM276
02

Mechanism of action

None known

03

Biological functions

Other (no well-established function in the literature; predicted to be involved in zinc ion binding and membrane biology)
04

Disease associations

Other (no direct links to specific diseases or roles as a driver in cancer, inflammation, neurodegeneration, etc., in current literature)
05

Safety considerations

None known
06

Interacting drugs

None known
07

Biomarkers

None known

Beyond the preview

Go deeper on Transmembrane protein 276 (TMEM276).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Transmembrane protein 276 (TMEM276).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call